These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24435068)

  • 1. Effectiveness of bevacizumab for radiation-induced cerebral necrosis in children.
    Preuss M; Hirsch W; Hoffmann KT; Bernhard MK; Siekmeyer M; Kiess W; Meixensberger J; Wurm RE; Merkenschlager A
    Pediatr Neurosurg; 2013; 49(2):81-5. PubMed ID: 24435068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
    Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
    J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.
    Levegrün S; Hof H; Essig M; Schlegel W; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):796-808. PubMed ID: 15183483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET.
    Furuse M; Nonoguchi N; Kawabata S; Yoritsune E; Takahashi M; Inomata T; Kuroiwa T; Miyatake S
    Jpn J Clin Oncol; 2013 Mar; 43(3):337-41. PubMed ID: 23303838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery.
    Williams BJ; Park DM; Sheehan JP
    J Neurosurg; 2012 May; 116(5):972-7. PubMed ID: 22324417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges with the diagnosis and treatment of cerebral radiation necrosis.
    Chao ST; Ahluwalia MS; Barnett GH; Stevens GH; Murphy ES; Stockham AL; Shiue K; Suh JH
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):449-57. PubMed ID: 23790775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
    Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
    Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbaric oxygen therapy for treatment of adverse radiation effects after stereotactic radiosurgery of arteriovenous malformations: case report and review of literature.
    Wanebo JE; Kidd GA; King MC; Chung TS
    Surg Neurol; 2009 Aug; 72(2):162-7; discussion 167-8. PubMed ID: 18786715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
    Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
    Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-shot bevacizumab for cerebral radiation injury.
    Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
    BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral radiation necrosis complicating stereotactic radiosurgery for arteriovenous malformation.
    Statham P; Macpherson P; Johnston R; Forster DM; Adams JH; Todd NV
    J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):476-9. PubMed ID: 2199611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bevacizumab on radiation necrosis of the brain.
    Gonzalez J; Kumar AJ; Conrad CA; Levin VA
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Safety and Efficacy of Bevacizumab for Radiosurgery - Induced Steroid - Resistant Brain Edema; Not the Last Part in the Ship of Theseus.
    Tripathi M; Ahuja CK; Mukherjee KK; Kumar N; Dhandapani S; Dutta P; Kaur R; Rekhapalli R; Batish A; Gurnani J; Kamboj P; Agrahari A; Kataria K
    Neurol India; 2019; 67(5):1292-1302. PubMed ID: 31744962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 Cases.
    Hu Q; Zhao J; Xu J; Zhou X; Shui Y; Shen L; Wei Q
    Oncol Res Treat; 2017; 40(3):133-137. PubMed ID: 28231593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
    Torcuator R; Zuniga R; Mohan YS; Rock J; Doyle T; Anderson J; Gutierrez J; Ryu S; Jain R; Rosenblum M; Mikkelsen T
    J Neurooncol; 2009 Aug; 94(1):63-8. PubMed ID: 19189055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: dose/volume-response relations.
    Levegrün S; Hof H; Essig M; Schlegel W; Debus J
    Strahlenther Onkol; 2004 Dec; 180(12):758-67. PubMed ID: 15592695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
    Ma Y; Zheng C; Feng Y; Xu Q
    J Craniofac Surg; 2017 Sep; 28(6):e569-e571. PubMed ID: 28749838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
    Lubelski D; Abdullah KG; Weil RJ; Marko NF
    J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.
    Boström JP; Seifert M; Greschus S; Schäfer N; Glas M; Lammering G; Herrlinger U
    Strahlenther Onkol; 2014 Apr; 190(4):416-21. PubMed ID: 24429478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.